Literature DB >> 20828772

Seroepidemiology of hepatitis A and hepatitis E viruses in Aden, Yemen.

Amen Ahmed Bawazir1, C Anthony Hart, Tallal A Sallam, Christopher M Parry, Nicholas J Beeching, Luis E Cuevas.   

Abstract

The burden of hepatitis A (HAV) and hepatitis E (HEV) infection is unknown in Aden, Yemen. This survey describes the prevalence of antibodies against HAV and HEV among individuals attending primary health care facilities in Aden, Yemen. Five hundred and thirty eight participants, stratified by age and district population size, were enrolled and screened for anti-HAV and 356 for anti-HEV antibodies. The age-standardized seroprevalence of antibodies was 86.6% (95% CI 83.7-89.5) for anti-HAV and 10.7% (95% CI 7.5-13.9) for anti-HEV. The prevalence of anti-HAV and anti-HEV ranged from 53% and 0% in infants to 100% and 15.3% in participants >18 years old, respectively (P<0.001). Viral hepatitis remains a major public health problem in Aden with trends of hyperendemicity for both infections. Priority should be given to improve water quality, sanitation coverage, and food hygiene and increase public health awareness concerning the risk of contracting infection.
Copyright © 2010 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20828772     DOI: 10.1016/j.trstmh.2010.08.007

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  8 in total

Review 1.  Hepatitis E virus in the countries of the Middle East and North Africa region: an awareness of an infectious threat to blood safety.

Authors:  Soha Yazbek; Khalil Kreidieh; Sami Ramia
Journal:  Infection       Date:  2015-06-26       Impact factor: 3.553

Review 2.  Light and Darkness: Prevalence of Hepatitis E Virus Infection among the General Population.

Authors:  José-Manuel Echevarría
Journal:  Scientifica (Cairo)       Date:  2014-02-10

3.  Epidemiology of hepatitis E virus in China: results from the Third National Viral Hepatitis Prevalence Survey, 2005-2006.

Authors:  Zhiyuan Jia; Yao Yi; Jianhua Liu; Jingyuan Cao; Yong Zhang; Ruiguang Tian; Tao Yu; Hao Wang; Xinying Wang; Qiudong Su; Wenting Zhou; Fuqiang Cui; Xiaofeng Liang; Shengli Bi
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

4.  Hepatitis A and E seroprevalence and associated risk factors: a community-based cross-sectional survey in rural Amazonia.

Authors:  Claudia Lamarca Vitral; Mônica da Silva-Nunes; Marcelo Alves Pinto; Jaqueline Mendes de Oliveira; Ana Maria Coimbra Gaspar; Rebeca Cristina Costa Pereira; Marcelo Urbano Ferreira
Journal:  BMC Infect Dis       Date:  2014-08-23       Impact factor: 3.090

5.  Prevalence of hepatitis A across various countries in the Middle East, African and Eastern European countries.

Authors:  Abbolmajid Ghasemian
Journal:  Caspian J Intern Med       Date:  2016

Review 6.  Seroprevalence of Hepatitis E Virus Infection in Middle Eastern Countries: A Systematic Review and Meta-Analysis.

Authors:  Fadi S Qashqari
Journal:  Medicina (Kaunas)       Date:  2022-07-06       Impact factor: 2.948

7.  Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran.

Authors:  Khashayar Hesamizadeh; Heidar Sharafi; Hossein Keyvani; Seyed Moayed Alavian; Azar Najafi-Tireh Shabankareh; Roghiyeh Sharifi Olyaie; Maryam Keshvari
Journal:  Hepat Mon       Date:  2016-01-23       Impact factor: 0.660

8.  Setting a Course for Preventing Hepatitis E in Low and Lower-Middle-Income Countries: A Systematic Review of Burden and Risk Factors.

Authors:  Aybüke Koyuncu; Daniel Mapemba; Iza Ciglenecki; Emily S Gurley; Andrew S Azman
Journal:  Open Forum Infect Dis       Date:  2021-04-13       Impact factor: 3.835

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.